3D in vitro blood–brain barrier models: recent advances and their role in brain disease research and therapy
Authors:
Open Access
- 7 October 2025
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 16, 1637602
Abstract
The blood-brain barrier (BBB) is a dynamic and highly selective interface crucial to central nervous system (CNS) homeostasis, presenting a major challenge for effective drug delivery in treating CNS pathologies such as brain tumours and neurodegenerative disease. Traditional two-dimensional (2D) in vitro models and animal models often fail to replicate the structural complexity and physiological functions of the human BBB. Recent advances in three-dimensional (3D) in vitro modelling offer enhanced physiological relevance by integrating cellular architecture, extracellular matrix (ECM) components, and dynamic fluid flow to simulate in vivo conditions more accurately. This review explores the structural and functional features of the BBB and highlights the evolution from 2D to 3D in vitro models, including hydrogel-based systems, microfluidics, organ-on-a-chip (OOAC) platforms, spheroids and organoids. The advantages of these models in recapitulating BBB dynamics and their application in cancer research and other CNS diseases are discussed. Finally critical comparison and discussion of current 3D models is presented, highlighting differences and best potential uses of each variation. Continued advancements are needed to develop accurate 3D in vitro models of the BBB in order to revolutionize drug screening, predict therapeutic efficacy, and support personalized medicine approaches. By providing robust, human-relevant platforms, 3D BBB models can accelerate drug development and treatment for patients affected by CNS pathologies.Keywords
This publication has 253 references indexed in Scilit:
- 3D In Vitro Blood‐Brain‐Barrier Model for Investigating Barrier InsultsAdvanced Science, 2023
- Hyperglycemic Neurovasculature‐On‐A‐Chip to Study the Effect of SIRT1‐Targeted Therapy for the Type 3 Diabetes “Alzheimer's Disease”Advanced Science, 2022
- Triculture Model of In Vitro BBB and its Application to Study BBB‐Associated Chemosensitivity and Drug Delivery in GlioblastomaAdvanced Functional Materials, 2021
- A Microfluidic Multisize Spheroid Array for Multiparametric Screening of Anticancer Drugs and Blood–Brain Barrier Transport PropertiesAdvanced Science, 2021
- A 3D Biohybrid Real‐Scale Model of the Brain Cancer Microenvironment for Advanced In Vitro TestingAdvanced Materials Technologies, 2020
- A pump‐free tricellular blood–brain barrier on‐a‐chip model to understand barrier property and evaluate drug responseBiotechnology and Bioengineering, 2019
- Blood–Brain Barrier Dysfunction in a 3D In Vitro Model of Alzheimer's DiseaseAdvanced Science, 2019
- Assessment of hydrogels for bioprinting of endothelial cellsJournal of Biomedical Materials Research Part A, 2017
- In Vitro Microfluidic Models for Neurodegenerative DisordersAdvanced Healthcare Materials, 2017
- Microfluidic blood–brain barrier model provides in vivo‐like barrier properties for drug permeability screeningBiotechnology and Bioengineering, 2016